US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals

IHH Healthcare Says India Supreme Court Disposes of Fortis Forensic Audit Petition

MT Newswires Live

Epiminder sets virtual AGM as FDA‑cleared Minder EEG device gains clinical traction

Promisia moves to fast-track full ownership of Golden View Village

NeOnc Plans FDA End-of-Phase 1 Meeting for NEO212

SI-BONE Receives FDA 510(k) Approval for Spinal Fusion System

MT Newswires Live

Healthcare Stocks Rise to Start Week

Teva Reports FDA Approval for Degevma

MT Newswires Live

SI-Bone announces FDA 510(k) clearance of iFuse Granite Onyx System

SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds Lower as US Equities Decline After Midday

MT Newswires Live

Cryoport management to meet with BTIG

Diagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

CapsoVision Wins FDA Clearance for AI Endoscopy Tool

King International Wins Shareholder Backing for Share Consolidation and Major Rights Issue

CervoMed neflamapimod update removes key overhang, says Jones

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.05546,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.05546,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671298192","title":"Buy Rating Backed by Strong Rare Liver Disease Franchise, Expanding Commercial Footprint, and Favorable Risk‑Reward at Mirum Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298192","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298192?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:55","pubTimestamp":1790657719,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Joseph Schwartz from Leerink Partne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-backed-by-strong-rare-liver-disease-franchise-expanding-commercial-footprint-and-favorable-riskreward-at-mirum-pharmaceuticals-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-backed-by-strong-rare-liver-disease-franchise-expanding-commercial-footprint-and-favorable-riskreward-at-mirum-pharmaceuticals-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","XLV","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298622","title":"IHH Healthcare Says India Supreme Court Disposes of Fortis Forensic Audit Petition","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298622","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298622?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:54","pubTimestamp":1790657698,"startTime":"0","endTime":"0","summary":"IHH Healthcare  said India's Supreme Court on Sept. 25, Friday, disposed of Fortis Healthcare's  Special Leave Petition challenging a Delhi High Court order requiring a forensic audit of Fortis and certain observations concerning the company.The company's unit, Northern TK Venture, acquired a 31% stake in Fortis in 2018 through a competitive bidding process, involving a 40 billion rupees preferential allotment and a mandatory tender offer to public shareholders.IHH said the acquisition was completed months after former Fortis promoters Malvinder and Shivinder Singh had resigned from the company's board in March 2018. It said no secondary shares were acquired from them and no payments were made to them, adding that it was not a party to the dispute between Daiichi Sankyo and the former promoters.The healthcare company said it will cooperate fully with the forensic audit and remains committed to Fortis, with plans to increase its stake to 51% over the next three to five years.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6092","BK4588","XLV","Q0F.SI","LU0029874061.USD","BK4585","MNDmain","HCSG","BK6511","XBI","BK4137","LABU","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671298394","title":"Epiminder sets virtual AGM as FDA‑cleared Minder EEG device gains clinical traction","url":"https://stock-news.laohu8.com/highlight/detail?id=2671298394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671298394?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:27","pubTimestamp":1790656036,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Epiminder Ltd. ( ($AU:EPI) ). Epiminder Limited has called its Annual General Meeting for 30 October 2026, sche...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epiminder-sets-virtual-agm-as-fdacleared-minder-eeg-device-gains-clinical-traction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epiminder-sets-virtual-agm-as-fdacleared-minder-eeg-device-gains-clinical-traction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPI","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671260263","title":"Promisia moves to fast-track full ownership of Golden View Village","url":"https://stock-news.laohu8.com/highlight/detail?id=2671260263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671260263?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:18","pubTimestamp":1790655481,"startTime":"0","endTime":"0","summary":"Promisia Healthcare Limited ( ($NZ:PHL) ) has issued an update. Promisia Healthcare has secured an option to accelerate its acquisition of the Gold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/promisia-moves-to-fast-track-full-ownership-of-golden-view-village?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/promisia-moves-to-fast-track-full-ownership-of-golden-view-village?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAU","XLV","MGCmain","NUGT","GLD","SGUmain","BK4588","BK4585","159934","518880","BK4581","GCmain","GDX","LABU","XBI","DUST","SGCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671268127","title":"NeOnc Plans FDA End-of-Phase 1 Meeting for NEO212","url":"https://stock-news.laohu8.com/highlight/detail?id=2671268127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671268127?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:28","pubTimestamp":1790630903,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings, Inc. ( ($NTHI) ) just unveiled an update. NeOnc Technologies announced on September 28, 2026, that it is scheduled to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neonc-plans-fda-end-of-phase-1-meeting-for-neo212?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neonc-plans-fda-end-of-phase-1-meeting-for-neo212?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671686112","title":"SI-BONE Receives FDA 510(k) Approval for Spinal Fusion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2671686112","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671686112?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:24","pubTimestamp":1790630642,"startTime":"0","endTime":"0","summary":"SI-BONE  said late Monday it received a 510 clearance from the US Food and Drug Administration for the iFuse Granite Onyx system to treat screw loosening in spinal fusion procedures, especially in patients with low bone density.The system allows for rapid osseointegration and lower micromotion to aim for early fixation and reduced screw loosening, according to a statement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","BK4588","LABU","BK4585","SIBN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671686982","title":"Healthcare Stocks Rise to Start Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2671686982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671686982?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:19","pubTimestamp":1790630340,"startTime":"0","endTime":"0","summary":"Shares of health care companies were among the few winning sectors Monday as the broader market posted losses.Roche Holding said it stopped work on one of its obesity-drug candidates, after clinical-trial data suggested the medicine wouldn't hit internal targets. The Swiss drugmaker said it returned rights to the medicine, emugrobart, to its majority-owned business Chugai Pharmaceutical  which originally discovered the drug and licensed it to Roche. \"We have made the decision to discontinue development,\" Roche's pharmaceuticals chief executive, Teresa Graham, said at an event with investors in London on Monday. \"We are returning that molecule to Chugai, and Chugai is looking to further development in [spinal muscular atrophy] as well as considering potential outlicensing opportunities.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","XBI","XLV","HCSG","BK4585","BK4581","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250803","title":"Teva Reports FDA Approval for Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250803","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250803?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:25","pubTimestamp":1790627151,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said late Monday the US Food and Drug Administration has approved Degevma as a biosimilar to Xgeva.Degevma is indicated for the prevention of bone complications in adults with advanced cancer that has spread to the bone, it said.The drug is also indicated for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone and for the treatment of hypercalcemia of malignancy, Teva said.Teva said it expects to launch Degevma and Ponlimsi in the US in the coming months. Ponlimsi was approved in March.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983299246.USD","BK4596","LABU","BK4007","LU2324357040.USD","BK4566","BK4585","TEVA","BK4584","BK4588","BK4559","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250198","title":"SI-Bone announces FDA 510(k) clearance of iFuse Granite Onyx System","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250198?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:15","pubTimestamp":1790626541,"startTime":"0","endTime":"0","summary":"SI-Bone (SIBN) announced FDA 510(k) clearance for the iFuse Granite Onyx System. This is SI-Bone’s first product addressing the problem of compromi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/si-bone-announces-fda-510k-clearance-of-ifuse-granite-onyx-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/si-bone-announces-fda-510k-clearance-of-ifuse-granite-onyx-system-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588","ONYXU","SIBN","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505722","title":"SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505722","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505722?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:09","pubTimestamp":1790626140,"startTime":"0","endTime":"0","summary":"FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density boneSANTA CLARA, Calif., Sept.  28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global l","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370259/0/en/si-bone-receives-fda-510-k-clearance-for-ifuse-granite-onyx-extending-its-compromised-bone-franchise-beyond-the-pelvis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONYXU","BK4585","BDD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","NVIB","PSCH","TECB","MEDI","LU2324357040.USD","BK4007","TEVA","BK4585","BMED","IEIH","LU1983299246.USD","BK4559","IYH","MRNX","MRNY","BK4584","SYNB","BK4596","GNMX","IBB","BK4557","BBP","LABU","RSPH","BK4588","BK4566","GDOC","TBXU","FRTY","PINK","LFSC","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505252","title":"Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505252","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505252?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625600,"startTime":"0","endTime":"0","summary":"DEGEVMA is now FDA-approved across all indications of the reference product, Xgeva (denosumab), to help prevent bone complications in adults with advanced cancer that has spread to the bone, for the t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370248/0/en/teva-continues-biosimilar-momentum-with-u-s-fda-approval-of-degevma-denosumab-adet-a-biosimilar-to-xgeva-denosumab.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVF","BK4156","BK4585","BK4588","LABU","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257344","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257344?lang=en_us&edition=fundamental","pubTime":"2026-09-29 03:32","pubTimestamp":1790623963,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each adding 0.3%.The iShares Biotechnology ETF  rose 0.8%.In corporate news, Eli Lilly  plans to pursue larger pharmaceutical deals as it looks to expand into new therapeutic areas, Bloomberg reported, citing an interview with CEO David Ricks on the sidelines of a diabetes conference in Milan. Ricks cited infectious disease, women's health, and psychiatric conditions as possible areas of opportunity in a broadening search for pharmaceutical deals, the report said. Lilly shares were up 0.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B1BXHZ80.USD","LLY","LU0266013472.USD","IE00BWXC8680.SGD","IXJ","LU0432979614.USD","LLYZ","LLYX","LU0079474960.USD","ILDR","LU0320765059.SGD","LU1629891620.HKD","LU0640476718.USD","LU2324357040.USD","PJP","IE00B7KXQ091.USD","LU0823416689.USD","SG9999015945.SGD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","IE0002141913.USD","LU2471134879.HKD","LU0316494557.USD","LU0353189763.USD","LU1291159041.SGD","LU0096364046.USD","LU0133085943.USD","LU0158827948.USD","SG9999018857.SGD","IE00BJLML261.HKD","TMED","AGNG","SG9999001176.SGD","LU0289739699.SGD","LU2491049909.HKD","LLII","BK4585","LU2264538146.SGD","IE00BJT1NW94.SGD","LU0471298694.HKD","LU1974910355.USD","LU2756315664.SGD","WDNA","LU2271345857.HKD","SGXZ31699556.SGD","LU0823434583.USD","ELIL","ELIS","LU1023059063.AUD","LU1366192091.USD","LU1988902786.USD","LU2211815571.USD","LU2750360641.GBP","LU0109394709.USD","LU1712237335.SGD","LU1868836914.USD","LU0943347566.SGD","IE00BKPKM429.USD","BK4007","SGXZ51526630.SGD","LU1979441026.SGD","LU0094547139.USD","LU2361044949.HKD","IYH","LU2360106947.USD","XBI","LU1064131342.USD","LU1061106388.HKD","IE0004445015.USD","LU0823434740.USD","LU1691799644.USD","LU1267930730.SGD","LU0466842654.USD","LU2106854487.HKD","LU0345770993.USD","LU2028103732.USD","LU0174119429.USD","LU2361045086.USD","LU0061475181.USD","SG9999013999.USD","JDOC","IE00B4R5TH58.HKD","GDOC","LU0114720955.EUR","LU0689472784.USD","LU0320765992.SGD","LU1868836591.USD","LU2456880835.USD","LU1232071149.USD","VHT","LU2112291526.USD","BK4516","LABU","BK4581","IE00B2B36J28.USD","LU2063271972.USD","IE0005OL40V9.USD","LU2023251221.USD","LU2213496289.HKD","LU1720051108.HKD","LU2462157665.USD","LU1551013342.USD","IE0009355771.USD","LU2089284900.SGD","TRUH","LU1814569148.SGD","LU2237443465.HKD","LU0234572021.USD","SG9999015986.USD","BK4588","LU0456855351.SGD","LU0006306889.USD","LU0158827781.USD","HRTS","IE00BN29S564.USD","LU0198837287.USD","OZEM","LU1093756168.USD","SG9999001176.USD","LU0672654240.SGD","LU0820562030.AUD","LU2023250330.USD","LU1093756325.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0122379950.USD","LU2552382132.HKD","LU0256863902.USD","IE00BFSS8Q28.SGD","LU0354030438.USD","LU0385154629.USD","LU0882574055.USD","LU1057294990.SGD","LU2237443978.SGD","LU2462591350.SGD","LU0238689110.USD","LU2896262040.SGD","LU2237443382.USD","IE0001KFT4U8.USD","LU0889565916.HKD","IE00B1XK9C88.USD","LU2089283258.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU2111349929.HKD","LU2237438978.USD","LU2471134952.CNY","LU2552382058.USD","LU2168564149.EUR","LU2746668461.USD","LU0225283273.USD","MEDI","LU2461242641.AUD","FTXH","IE00B775H168.HKD","LU0820561909.HKD","LU2468319806.SGD","LU0820561818.USD","LU2602419157.SGD","LU2087625088.SGD","FHLC","LU1720051017.SGD","IE00BK4W5L77.USD","LU0058720904.USD","LU0417517546.SGD","IE00B4JS1V06.HKD","LU2491050154.USD","LU0708995401.HKD","SG9999015978.USD","LU1868837136.USD","LU2552382215.SGD","LU2746668974.SGD","LU0787776722.HKD","LU0203201768.USD","BK4534","MHIP","LU0109391861.USD","LU1917777945.USD","LU2089984988.USD","LU2237443549.SGD","LU2756315318.SGD","IE0004445239.USD","PPH","LU0786609619.USD","LU2417539215.USD","RXL","LU2168564222.USD","LU2236285917.USD","LU0323591593.USD","LU2237443622.USD","LU2471134796.USD","IE00BKDWB100.SGD","SGXZ99366536.SGD","LU2237443895.HKD","LU1989771016.USD","LU0964807845.USD","LU1623119135.USD","SG9999017495.SGD","LU1551013425.SGD","LU2168564495.EUR","LU2471134523.USD","LU2750360997.AUD","LU1127390331.HKD","LU0353189680.USD","LU0256863811.USD","SG9999014914.USD","IHE","THNR","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2361044865.SGD","IE00BFSS7M15.SGD","LU0210536198.USD","LU2357305700.SGD","SG9999014898.SGD","BK4533","LU1035775433.USD","SGXZ81514606.USD","CURE","XLV","MEDX","LU1069344957.HKD","LU1804176565.USD","LU0203202063.USD","LU1145028129.USD","SG9999015952.SGD","CANC","LU1983299246.USD","LU2023250504.SGD","LU0106261372.USD","LU1548497426.USD","LU1280957306.USD","LU1868836757.USD","LU0097036916.USD","LU2265009873.SGD","IE00BJJMRX11.SGD","LU2168563687.JPY","SG9999014906.USD","LU2108987350.USD","BK4599","IBB","LU0471298777.SGD","LU0354030511.USD","LU0882574139.USD","IE00BJJMRY28.SGD","LU0345770308.USD","LU1323610961.USD","SG9999014880.SGD","LU0683600562.USD","SG9999018865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671543832","title":"Exchange-Traded Funds Lower as US Equities Decline After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2671543832","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671543832?lang=en_us&edition=fundamental","pubTime":"2026-09-29 01:26","pubTimestamp":1790616373,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV fell. Actively traded Invesco QQQ Trust (QQQ) shed 1%.US equity indexes fell in midday trading on Monday as oil prices and Treasur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GPIQ","BITO","IAUI","IYH","SBIT","SPXU","YGLD","BTCC","FAZ","ETHT","DEFI","CBOA","HODL","GBTC","VIS","BITU","ETHD","ETQ","BK4593","OUNZ","XBTY","YBTC","SPUU","VDC","SOXL","SSO","TETH","SOXX","ETH.USD.CC","CBTJ",".SPX","DFII","BETH","NAPR","SCO","XLY","IWMI","SDS","QDEC","ARKB","MNQmain","CBOO","QLD","XLP","SPXS","BTCZ","BAR","FBTC","MMAX","BITI","SETH","VHT","BK4547","BK4581","SRTY","TZA","TQQQ","RSSL","AVUV","SPDN","NOCT","IWN","GLDM","ETCO","VB","BK4585","FAS","MAXI","XLPD","BTC.USD.CC","IAU","UGL","GLD","SLV","QQQM","XLI","XLK","BGLD","BTF","RTH","SOXS","BCCC","BRRR","IVV","KGLD","SPYU","CBXY","BAGY","RYLD","RWM","BK4534","TNA","BK4504","UCO","IWF","SPYM","CBTO","IYW","ETH","BITX","USG","DGZ","SPY","NDX","RETL","CBXJ","UNG","XSD","CBOY","QQQ","BETE","BK4535","ESK","HIBL","IBIT","SPYH","URTY","BFJL","IYE","USO","VTWO","DMAX","XLE","XLF","BTCW","DGP","IBB","CBTA","TWM","QID","XLV","BITB","TECL","SIVR","GLDY","XAGUSD.FOREX","CBOJ","GLL","BFAP","XBI","DULL","SH","XRT","SGOL","QQQX","YSPY","TQQY","BK4588","BK4561","BTRN","EETH","XLPU","BTCL","CBTY","LABU","BTCO","PSQ","SMAX","SQQQ","XAUUSD.FOREX","QMAR","BITY","IGM","QBF","CBXA","EZBC","IWM","IYJ","AAAU","FGDL","NJAN","IAUM","NJUL","USSX","BK4550","SPXL","ZSL","SPYQ","BPI","IGLD","CBXO","UPRO","BTC","SHNY","AGQ","BK4570","UWM","MNRS","DZZ","BTCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254672","title":"Cryoport management to meet with BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671254672?lang=en_us&edition=fundamental","pubTime":"2026-09-29 01:25","pubTimestamp":1790616317,"startTime":"0","endTime":"0","summary":"Healthcare IT & Digital Health Analyst Larsen holds a Field Trip to New York on October 7 and New Jersey on October 8 hosted by BTIG. Published fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cryoport-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cryoport-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4581","BK4585","XLV","XBI","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671515512","title":"Diagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System","url":"https://stock-news.laohu8.com/highlight/detail?id=2671515512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671515512?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:36","pubTimestamp":1790613382,"startTime":"0","endTime":"0","summary":"An announcement from Diagnos ( ($TSE:ADK) ) is now available. Diagnos has submitted a Section 513(g) Request for Information to the U.S. Food and D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/diagnos-seeks-u-s-fda-clarity-on-ai-powered-cara-eye-screening-system?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/diagnos-seeks-u-s-fda-clarity-on-ai-powered-cara-eye-screening-system?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTHR","QTOC","AIPO","BK4007","CARA","LABU","ARTY","BK4585","CHAT","AGIX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362540622.SGD","HCSG","IBB","LU2106854487.HKD","LU0882574055.USD","LU0823434583.USD","LABU","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU0823434740.USD","LU2237438978.USD","XLV","XBI","LU2468319806.SGD","LU0053666078.USD","LU2362541513.USD","LU2089984988.USD","BK4505","BK4137","LU1917777945.USD","KOD","LU0109394709.USD","BK4585","BK4139","LU0320765992.SGD","LU0058720904.USD","LU0029874061.USD","LU1974910355.USD","LU2362541273.HKD","LU0889565916.HKD","BBH","BK4588","BK4581","REGN","LU0128526141.USD","TBXU","IBBQ","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256083","title":"CapsoVision Wins FDA Clearance for AI Endoscopy Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256083?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:27","pubTimestamp":1790609272,"startTime":"0","endTime":"0","summary":"CapsoVision, Inc. ( ($CV) ) has shared an update. CapsoVision, Inc., a NASDAQ-listed medical technology company specializing in AI-enabled capsule ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/capsovision-wins-fda-clearance-for-ai-endoscopy-tool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/capsovision-wins-fda-clearance-for-ai-endoscopy-tool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQJ","CHAT","QQQE","TECS","SQQQ","XHE","BK4585","NQmain","QDTE","NVIW.SI","TQQQ","QYLG","QQQY","DTEC","03086","QID","ARTY","LABU","HTEC","ONEQ","PSQ","FTEC","BK4588","CV","BK4082","AIPO","MNQmain","QLD","QQQ","AGIX","QQQA","TQQY","JEPQ","IYW","QQQM","VTHR","FWD","GPIQ",".IXIC","QTOC","NDX","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256150","title":"King International Wins Shareholder Backing for Share Consolidation and Major Rights Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256150?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:08","pubTimestamp":1790608084,"startTime":"0","endTime":"0","summary":"Life Healthcare Group ( ($HK:0928) ) has issued an update. King International Investment Limited has secured shareholder approval for a share conso...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/king-international-wins-shareholder-backing-for-share-consolidation-and-major-rights-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/king-international-wins-shareholder-backing-for-share-consolidation-and-major-rights-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNA","XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670253220","title":"CervoMed neflamapimod update removes key overhang, says Jones","url":"https://stock-news.laohu8.com/highlight/detail?id=2670253220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670253220?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:05","pubTimestamp":1790604345,"startTime":"0","endTime":"0","summary":"Jones analyst Boris Peaker says CervoMed (CRVO) announced this morning that the FDA removed neflamapimod’s prior drug exposure limit, allowing the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cervomed-neflamapimod-update-removes-key-overhang-says-jones-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cervomed-neflamapimod-update-removes-key-overhang-says-jones-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":8,"totalSize":395,"code":"91000000","status":"200"}]}}